Among those genes relevant to DCM, myocardial-related genes (tnnc2, myhz1.1, tpm4b, myh6, myh7, myh7ba, scl8a1a, atp1b2a and cacng3b) and cardiovascular development-related genes (vegfc, nkx2.7, heg1, ccm2, ccm2l, klf2a, kdrl, id4 and fosl2) were revealed to be changed in NXT  +  TFD treated embryos compared with TFD-induced cardiomyopathy embryos as indicated by RNA-seq analysis. This evidence concerns the gene CCM2 and cardiomyopathy.